WBA Stock Recent News

WBA delivers better-than-expected earnings and revenues in the second quarter of fiscal 2025.

Shares in Walgreens Boots Alliance (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings. The results, which beat on earnings and revenue, are notable as they will be one of the last earnings reports the company posts as a publicly traded company.

Walgreens Boots Alliance (WBA) saw its second-quarter fiscal 2025 sales increase and its operating loss drop as it continues its turnaround plan and prepares to be acquired. The retail pharmacy company said in a Tuesday (April 8) earnings release that during the quarter ended Feb. 28, its sales rose 4.

Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its top line earnings beat, but he expects the planned merger to shake market movement.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday.

The headline numbers for Walgreens (WBA) give insight into how the company performed in the quarter ended February 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $1.20 per share a year ago.

CNBC's Becky Quick reports on the company's quarterly earnings results.

Walgreens Boots Alliance posted higher sales in its latest quarter on growth in retail-pharmacy sales in the U.S., in one of the last quarterly reports the company will publicly file ahead of its transition to a private company.

Walgreens reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant prepares to go private.  In this article WBA